One of the local biotechs developing a vaccine for COVID-19 has announced its second chief executive change in the last week amid rumors that President Donald Trump attempted to negotiate exclusive rights to the company’s drug.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,